Nuclear magnetic resonance spectroscopy: Its role in providing valuable insight into diverse clinical problems

Chest

Volumn 116, Issue 5, 1999, Pages 1434-1441

  McCully, Kevin ^a   Mancini, Donna ^b   Levine, Sanford ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b Columbia University ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Humans; Magnetic resonance spectroscopy; Metabolism; Muscle; Respiratory disease

Indexed keywords

AEROBIC METABOLISM; BREATHING; BREATHING MUSCLE; CARDIOVASCULAR FUNCTION; CELL PH; DIAGNOSTIC VALUE; HEART DISEASE; METABOLIC REGULATION; MUSCLE METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RESPIRATION CONTROL; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 0032743275     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1434     Document Type: Article

References (41)

1. 1 Levine S, Johnson B, McCully K. Exercise retraining. In: Cherniack N, ed. Pulmonary rehabilitation. New York, NY: McGraw Hill, 1998
2. 2 Mancini D, Coyle E, Coggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with heart failure. Circulation 1989; 80:1338-1346
3. 3 McCully KK. Magnetic resonance as a tool to study sarcopenia. Muscle Nerve 1997; 5(suppl):S102-S106
4. 4 VanDenThillart G, VanWaarde A. Nuclear magnetic resonance spectroscopy of living systems: applications in comparitive physiology. Physiol Rev 1996; 76:799-837
5. 5 Kent-Braun JA, Miller RG, Weiner MW. Human skeletal muscle metabolism in health and disease: utility of magnetic resonance spectroscopy. In: Holloszy JO, ed. Exercise and sports science reviews. Baltimore, MD: Williams & Wilkins, 1995; 305-347
6. 6 Kanal E, Shellock F. Safety considerations prevent harm in MRI. Magn Reson 1993; 3:30-40
7. 31P-MRS methods during exercise and recovery in men. J Appl Physiol 1994; 77:2194-2200
8. 8 Hetherington H, Pan J, Chu W, et al. Biological and clinical MRS at ultra-high field. NMR Biomed 1997; 10:360-371
9. 9 McCully K, Boden B, Tuchler M, et al. The wrist flexor muscles of elite rowers measured with magnetic resonance spectroscopy. J Appl Physiol 1989; 67:926-932
10. 10 McCully K, Vandenborne K, DeMeirleir K, et al. Muscle metabolism in track athletes using 31-P magnetic resonance spectroscopy. Can J Physiol Pharmacol 1992; 70:1353-1359
11. 11 Rodenburg J, DeBoer R, Jeneson J, et al. 31P-MRS and simultaneous quantification of dynamic human quadriceps exercise in a whole body MR scanner. J Appl Physiol 1994; 77:1021-1029
12. 12 Chance B, Leigh J, Kent J, et al. Multiple controls of oxidative metabolism of living tissues as studied by 31-P MRS. Proc Natl Acad Sci USA 1986; 83:9458-9462
13. 13 Mahler M. First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between Q02 and phosphorylereatine level. J Gen Physiol 1985; 86:135-165
14. 14 McCully K, Iotti S, Kendrick K, et al. Simultanious in vivo measurements of HbO2 saturation and PCr kinetics after exercise in normal humans. J Appl Physiol 1994; 77:5-10
15. 15 Miller RG, Giannini D, Milner-Brown HS, et al. Effects of fatiguing exercise on high-energy phosphates, force, and EMG: evidence for three phases of recovery. Muscle Nerve 1987; 10:810-821
16. 16 McCully K, Vandenborne K, Posner J, et al. Magnetic resonance in physiology and medicine. In: Gillies R, ed. MR in physiolgy and medicine. San Diego, CA: Academic Press, 1994; 405-412
17. 17 Mannix ET, Boska MD, Galassetti P, et al. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. J Appl Physiol 1995; 78:2218-2227
18. 18 Vandenborne K, McCully K, Kakihira H, et al. Metabolic heterogeneity in human calf muscle during maximal exercise. Proc Natl Acad Sci USA 1991; 88:5714-5718
19. 19 Kemp G, Taylor D, Styles P, et al. The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery. NMR Biomed 1993; 6:73-83
20. 20 Edwards RHT. Biochemical bases of fatigue in exercise performance: catastrophe theory of muscular fatigue. In: Knuttgen HG, Vogel JH, Poortmaas JH, eds. Internatational series of sports science, 1982; 3-28
21. 21 Nosek TM, Fender JY, Godt RE. It is diprotonated inorganic phosphate that depresses force in skinned skeletal muscle fibers. Science 1987; 236:191-193
22. 22 Wilson JR, McCully KK, Mancini DM, et al. Relationship of muscle fatigue to pH in man: a 31-phosphorus nuclear magnetic resonance study. J Appl Physiol 1988; 64:2333-2339
23. 23 Baker AJ, Kostov KG, Miller RG, et al. Slow force recovery after long duration exercise: metabolic and activation factors in muscle fatigue. J Appl Physiol 1993; 74:2294-2300
24. 24 McCully KK, Argov Z, Boden BP, et al. Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy. Muscle and Nerve 1988; 11:212-216
25. 25 Younkin DP, Berman P, Sladky J, et al. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987; 37:165-169
26. 26 Satrustegui J, Berkowitz H, Boden B, et al. An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiers' content of human muscle. Mech Ageing Dev 1988; 42:105-114
27. 27 Foley J, Harkema S, Meyer R. Decreased ATP cost of isometric contractions in ATP-depleted rat fast-twitch muscle. Am J Physiol 1991; 261(suppl):C872-C881
28. 28 Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:629-634
29. 29 Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153:976-980
30. 30 Whittom F, Jobin J, Simard P-M, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30:1467-1474
31. 31 Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374-377
32. 32 Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-293
33. 33 Breukink SO, Strijbos JH, Koorn M, et al. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease. Respir Med 1998; 92:676-682
34. 34 Serres I, Hayot M, Prefaut C, et al. Skeletal muscle abnormalities in patients with COPD: contribution to exercise intolerance. Med Sci Sports Exerc 1998; 30:1019-1027
35. 35 Kutsuzawa T, Shioya S, Kurita D, et al. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:647-652
36. 36 Fregosi R. Invited editorial on "importance of lactate anion in control of breathing." J Appl Physiol 1998; 84:409-410
37. 37 Levine S. Nonperipheral chemoreceptor stimulation of ventilation by cyanide. J Appl Physiol 1975; 39:199-204
38. 38 Oelberg D, Evans A, Hrovat M, et al. Skeletal muscle chemoreflex and pHi in exercise ventilatory control. J Appl Physiol 1998; 84:676-682
39. 39 Mancini D, Beniaminovitz A. Exercise training in patients with heart failure. In: Hosenbud and Greenburg, eds. Congestive heart failure. 2nd ed. (in press)
40. 40 Massie B, Conway M, Yonge R, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 1989; 78:320-326
41. 41 Wiener D, Fink L, Maris J, et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986; 73: 1127-1136